Conversely, the TLR4 inhibitor C34 had no inhibitory effect on unactivated MPN (0.98 ± 0.03), activated MPN (1.02 ± 0.02), or activated controls (0.84 ± 0.06) (Figure 6(b)). The gene discussed is TLR4; the disease is myeloproliferative neoplasm.